Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 45 Records) |
| Query Trace: Disease and EML4[original query] |
|---|
| Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Oncotarget 2016 Jul . Zhang Shirong, Xia Bing, Jiang Hong, Wang Limin, Xu Rujun, Shi Yanbin, Zhang Jianguang, Xu Mengnan, Cram David S, Ma Shengl |
| Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma. Journal of translational medicine 2016 06 14 (1): 188. Song Zhengbo, Yu Xinmin, Cheng Guoping, Zhang Yipi |
| Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China. Molecular and clinical oncology 2016 May 4 (5): 749-755. Chen Yun, Ye Lijuan, Stanford Rebecca Rongrong, Zhang Dongfang, Zhang Xingsong, Wei Wan |
| Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr . Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu |
| Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. Gastroenterology 2016 Apr . Yaeger Rona, Shah Manish A, Miller Vincent A, Kelsen Judith R, Wang Kai, Heins Zachary J, Ross Jeffrey S, He Yuting, Sanford Eric, Yantiss Rhonda K, Balasubramanian Sohail, Stephens Philip J, Schultz Nikolaus, Oren Moshe, Tang Laura, Kelsen Dav |
| Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers. Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 122-134. Chapman Aaron M, Sun Kathie Y, Ruestow Peter, Cowan Dallas M, Madl Amy |
| An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung cancer (Amsterdam, Netherlands) 2017 11 113 30-36. Corrales-Rodríguez Luis, Arrieta Oscar, Mas Luis, Báez-Saldaña Renata, Castillo-Fernández Omar, Blais Normand, Martín Claudio, Juárez Melissa, Khanna Priyanka, Ramos-Esquivel Allan, Bacon Ludwing, Rojas Leonardo, Wills Beatriz, Oblitas George, Pérez María Angelina, Cuello Mauricio, Cardona Andrés Felipe, |
| Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants. Biochimie 2018 8 154 19-24. Mitiushkina Natalia V, Tiurin Vladislav I, Iyevleva Aglaya G, Kholmatov Maxim M, Filippova Elena A, Moiseyenko Fedor V, Levchenko Nikita E, Sardaryan Ivan S, Odintsova Svetlana V, Lozhkina Alexandra M, Volkov Nikita M, Karaseva Nina A, Moiseyenko Vladimir M, Orlov Sergey V, Imyanitov Evgeny |
| Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report. Cancer biology & medicine 2018 6 15 (2): 178-181. Zhang Ling, Li Yunxia, Zhang Shaohong, Gao Chen, Nie Keke, Ji Youx |
| Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers. International journal of cancer 2018 4 143 (7): 1696-1705. Luo Wenxin, Tian Panwen, Wang Yue, Xu Heng, Chen Lu, Tang Chao, Shu Yang, Zhang Shouyue, Wang Zhoufeng, Zhang Jun, Zhang Li, Jiang Lili, Liu Lunxu, Che Guowei, Guo Chenglin, Zhang Hong, Wang Jiali, Li Weim |
| Clinicopathological features of younger (aged ? 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thoracic cancer 2018 Mar . Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki |
Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis.
Human molecular genetics 2018 Oct . Fadista João, Skotte Line, Geller Frank, Bybjerg-Grauholm Jonas, Gørtz Sanne, Romitti Paul A, Caggana Michele, Kay Denise M, Matsson Hans, Boyd Heather A, Hougaard David M, Nordenskjöld Agneta, Mills James L, Melbye Mads, Feenstra Bjar |
| Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 8 14 (11): 1901-1911. Horn Leora, Whisenant Jennifer G, Wakelee Heather, Reckamp Karen L, Qiao Huan, Leal Ticiana A, Du Liping, Hernandez Jennifer, Huang Vincent, Blumenschein George R, Waqar Saiama N, Patel Sandip P, Nieva Jorge, Oxnard Geoffrey R, Sanborn Rachel E, Shaffer Tristan, Garg Kavita, Holzhausen Allison, Harrow Kimberly, Liang Chris, Lim Lee P, Li Mark, Lovly Christine |
| Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 3 14 (7): 1233-1243. Camidge D Ross, Dziadziuszko Rafal, Peters Solange, Mok Tony, Noe Johannes, Nowicka Malgorzata, Gadgeel Shirish M, Cheema Parneet, Pavlakis Nick, de Marinis Filippo, Cho Byoung Chul, Zhang Li, Moro-Sibilot Denis, Liu Ting, Bordogna Walter, Balas Bogdana, Müller Barbara, Shaw Alice |
| Genetic and transcriptional landscape of plasma cells in POEMS syndrome. Leukemia 2019 Jan . Nagao Yuhei, Mimura Naoya, Takeda June, Yoshida Kenichi, Shiozawa Yusuke, Oshima Motohiko, Aoyama Kazumasa, Saraya Atsunori, Koide Shuhei, Rizq Ola, Hasegawa Yoshinori, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Nishijima Dai, Isshiki Yusuke, Kayamori Kensuke, Kawajiri-Manako Chika, Oshima-Hasegawa Nagisa, Tsukamoto Shokichi, Mitsukawa Shio, Takeda Yusuke, Ohwada Chikako, Takeuchi Masahiro, Iseki Tohru, Misawa Sonoko, Miyano Satoru, Ohara Osamu, Yokote Koutaro, Sakaida Emiko, Kuwabara Satoshi, Sanada Masashi, Iwama Atsushi, Ogawa Seishi, Nakaseko Chia |
| Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma. Turk patoloji dergisi 2020 9 37 (1): 7-17. Bulutay P?nar, AkyÜrek Nalan, Memi? Ley |
| RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid : official journal of the American Thyroid Association 2020 6 30 (12): 1771-1780. Pekova Barbora, Sykorova Vlasta, Dvorakova Sarka, Vaclavikova Eliska, Moravcova Jitka, Katra Rami, Astl Jaromir, Vlcek Petr, Kodetova Daniela, Vcelak Josef, Bendlova Be |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
| Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2020 10 149 154-161. Tao Hong, Shi Liang, Zhou Aoxue, Li Hongxia, Gai Fei, Huang Zhan, Che Nanying, Liu Z |
| Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes. Journal of cancer research and clinical oncology 2020 Jan . Tian Panwen, Liu Yujie, Zeng Hao, Tang Yuan, Lizaso Analyn, Ye Junyi, Shao Lin, Li Yal |
| Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency. Clinical lung cancer 2021 1 22 (4): e519-e527. Bustamante Alvarez Jean G, Janse Sarah, Owen Dwight H, Kiourtsis Stephanie, Bertino Erin M, He Kai, Carbone David P, Otterson Gregory |
| Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 9 17 (12): 1404-1414. Ou Sai-Hong Ignatius, Nishio Makoto, Ahn Myung-Ju, Mok Tony, Barlesi Fabrice, Zhou Caicun, Felip Enriqueta, de Marinis Filippo, Kim Sang-We, Pérol Maurice, Liu Geoffrey, Migliorino Maria Rita, Kim Dong-Wan, Novello Silvia, Bearz Alessandra, Garrido Pilar, Mazieres Julien, Morabito Alessandro, Lin Huamao M, Yang Hui, Niu Huifeng, Zhang Pingkuan, Kim Edward |
| Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab. JAMA network open 2022 Jun 5 (6): e2215589. Liu Yufei, Zhang Zhe, Rinsurongkawong Waree, Gay Carl M, Le Xiuning, Ning Matthew S, Lewis Jeff, Rinsurongkawong Vadeerat, Lee J Jack, Roth Jack, Swisher Stephen, Gandhi Saumil, Lee Percy P, Gibbons Don L, Vaporciyan Ara A, Heymach John V, Zhang Jianjun, Lin Steven |
| Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in China. International journal of cancer 2022 5 152 (1): 15-23. Su Chunxia, Zhou Juan, Qiang Huiping, Zhao Jing, Chang Qing, Ji Xianxiu, Li Jiaqi, Xie Mengqing, Chu Tianqi |
| Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series. JCO precision oncology 2022 2 2 1-10. Jacobs Miriam T, Mohindra Nisha A, Shantzer Lindsey, Chen Ingrid L, Phull Hardeep, Mitchell William, Raymond Victoria M, Banks Kimberly C, Nagy Rebecca J, Lanman Richard B, Christensen James, Patel Jyoti D, Clarke Jeffrey, Patel Sandip |
| Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib. Translational cancer research 2022 2 8 (4): 1630-1634. Zhu You-Cai, Wan Bing, Wu Li-Xin, Li Xing-Liang, Wang Wen-Xian, Xu Chun-Wei, Zhuang Wu, Wei Jian-Guo, Du Kai- |
| Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer. Journal of thoracic disease 2023 8 15 (7): 3811-3817. Ashleigh Poh, Abdelaziz Sammour, Jared Mathai, Joanne Peverall, Chris Van Vliet, Khashayar Asadi, Sagun Para |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
| Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Ying Fu, Qing Liu, Xiaohan Wang, Liangchao Sun, Xiao Han, Xue Me |
| Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 11 . Paloma Navarro, Carmen Beato, Juan Francisco Rodriguez-Moreno, Sergio Ruiz-Llorente, Xabier Mielgo, Estela Pineda, Miguel Navarro, Gema Bruixola, Tatiana P Grazioso, Antonio Viudez, Jose Fuster, Esther Nogueron, Maria Dolores Mediano, Carmen Balaña, Carlos Mendez, Rosa María Rodriguez, Sonia Del Barco Berron, Beatriz Gongora, Alberto Carmona-Bayonas, Jesus Garcia-Don |
- Page last reviewed:Feb 1, 2024
- Content source: